KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $719,127,000 | +34.7% | 6,936,691 | +1.9% | 0.22% | +33.9% |
Q1 2017 | $534,069,000 | +94.9% | 6,804,291 | +11.4% | 0.17% | +88.8% |
Q4 2016 | $273,962,000 | -19.3% | 6,109,771 | +0.6% | 0.09% | -20.5% |
Q3 2016 | $339,384,000 | +12.9% | 6,075,623 | +1.0% | 0.11% | +8.7% |
Q2 2016 | $300,723,000 | +9.5% | 6,014,453 | +0.5% | 0.10% | +8.4% |
Q1 2016 | $274,668,000 | -25.0% | 5,982,753 | +0.7% | 0.10% | -24.0% |
Q4 2015 | $365,995,000 | +22.7% | 5,939,553 | +10.9% | 0.12% | +16.8% |
Q3 2015 | $298,303,000 | -10.8% | 5,357,460 | -2.3% | 0.11% | -2.7% |
Q2 2015 | $334,401,000 | +13.1% | 5,484,685 | +7.0% | 0.11% | +8.9% |
Q1 2015 | $295,603,000 | +32.9% | 5,124,885 | +32.9% | 0.10% | +32.9% |
Q4 2014 | $222,442,000 | +239.6% | 3,857,147 | +61.4% | 0.08% | +230.4% |
Q3 2014 | $65,505,000 | – | 2,389,185 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |